Zeteo Biomedical

Executive Summary

Zeteo Biomedical is a San Diego-based drug delivery company founded in 2016, focused on developing patient-centric delivery devices and primary container packaging. Serving pharmaceutical, biotech, and personal care companies, the company offers custom-configured systems for liquid, powder, and reconstituted powder formulations across multiple routes of administration. As a pre-clinical stage private entity, Zeteo aims to address the growing demand for differentiated drug delivery solutions that enhance patient compliance and drug stability. Its platform technology enables tailored delivery systems for both small molecules and biologics, positioning it for partnerships with drug developers. However, with no disclosed funding or valuation, assessment of its financial health and commercial traction remains challenging. The drug delivery market is competitive, but Zeteo's focus on customizability and patient-centric design could be key differentiators.

Upcoming Catalysts (preview)

• Q3 2026Partnership with Pharma for Drug-Device Combination30% success
• Q2 2026Completion of Prototype Testing for Novel Delivery System50% success
• 2026Series A Funding Round20% success